Serum nicotine metabolite profiles and their association with hematological, biochemical, and cardiovascular parameters in smokers

Abstract Objectives Cigarette smoking remains a major contributor to preventable cardiovascular morbidity and mortality. While the Fagerström Test for Nicotine Dependence (FTND) evaluates behavioral addiction, objective biochemical markers linking dependence severity to cardiovascular risk remain limited. This study investigated associations between serum nicotine metabolites, FTND, and Framingham Risk Score (FRS) in male smokers. Methods A cross-sectional study was performed in 104 male smokers aged 18–65 years. Nicotine dependence was assessed using the FTND. Serum nicotine, cotinine, norcotinine, and 3-hydroxycotinine levels were quantified by a validated LC–MS/MS method. Cardiovascular risk was estimated using the FRS, and correlations among metabolites, FTND scores, and smoking duration (pack-years) were analyzed. Results Nicotine metabolite concentrations across FTND dependence categories demonstrated increasing trends for cotinine and norcotinine. However, after adjustment for multiple comparisons using the Benjamini–Hochberg false discovery rate, only norcotinine levels differed significantly between FTND groups (q=0.030), with higher concentrations observed in individuals with greater dependence severity. Smoking duration expressed as pack-years showed a positive association with serum norcotinine concentrations, and this relationship remained statistically significant following FDR correction (r=0.327, q=0.008). Conclusions Norcotinine emerged as the most robust biochemical marker of nicotine dependence and cumulative tobacco exposure, linking behavioral addiction severity with long-term metabolic burden. The absence of associations between nicotine metabolites and FRS highlights the limited capacity of single time-point exposure markers to reflect multifactorial cardiovascular risk. These findings support the need for integrated behavioral and metabolic approaches in addiction assessment.

Authors

Institutions

Publication Details

Journal
Turkish Journal of Biochemistry
Published
2026-03-05
DOI
https://doi.org/10.1515/tjb-2025-0485
Primary Topic
Smoking Behavior and Cessation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum nicotine metabolite profiles and their association with hematological, biochemical, and cardiovascular parameters in smokers

Ali Ünlü, Mustafa Onmaz, Duygu Eryavuz Onmaz, NUR DEMIRBAS
Turkish Journal of Biochemistry
Smoking Behavior and Cessation
article

Serum nicotine metabolite profiles and their association with hematological, biochemical, and cardiovascular parameters in smokers

Ali Ünlü, Mustafa Onmaz, Duygu Eryavuz Onmaz, NUR DEMIRBAS
article en

Abstract

Abstract Objectives Cigarette smoking remains a major contributor to preventable cardiovascular morbidity and mortality. While the Fagerström Test for Nicotine Dependence (FTND) evaluates behavioral addiction, objective biochemical markers linking dependence severity to cardiovascular risk remain limited. This study investigated associations between serum nicotine metabolites, FTND, and Framingham Risk Score (FRS) in male smokers. Methods A cross-sectional study was performed in 104 male smokers aged 18–65 years. Nicotine dependence was assessed using the FTND. Serum nicotine, cotinine, norcotinine, and 3-hydroxycotinine levels were quantified by a validated LC–MS/MS method. Cardiovascular risk was estimated using the FRS, and correlations among metabolites, FTND scores, and smoking duration (pack-years) were analyzed. Results Nicotine metabolite concentrations across FTND dependence categories demonstrated increasing trends for cotinine and norcotinine. However, after adjustment for multiple comparisons using the Benjamini–Hochberg false discovery rate, only norcotinine levels differed significantly between FTND groups (q=0.030), with higher concentrations observed in individuals with greater dependence severity. Smoking duration expressed as pack-years showed a positive association with serum norcotinine concentrations, and this relationship remained statistically significant following FDR correction (r=0.327, q=0.008). Conclusions Norcotinine emerged as the most robust biochemical marker of nicotine dependence and cumulative tobacco exposure, linking behavioral addiction severity with long-term metabolic burden. The absence of associations between nicotine metabolites and FRS highlights the limited capacity of single time-point exposure markers to reflect multifactorial cardiovascular risk. These findings support the need for integrated behavioral and metabolic approaches in addiction assessment.

Turkish Journal of Biochemistry
Selçuk University (TR), Dokuz Eylül University (TR), Bandırma Onyedi Eylül University (TR), Necmettin Erbakan University (TR)
Good health and well-being
Openalex Percentile: Top 31%
Smoking Behavior and Cessation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.